Immunohistochemical identification of estrogen and progesterone receptor proteins in paraffin-embedded tissue: A protocol used in a busy immunohistochemistry laboratory

Journal of Histotechnology

Volumn 25, Issue 4, 2002, Pages 283-286

  Cartun, Richard W ^a   Mandich, Daniza ^a   Perkins, Mary L ^a   Stevens, Deborah Z ^a   Ricci Jr, Andrew ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

Antigen retrieval; Estrogen receptor protein; Immunoperoxidase; Progesterone receptor protein

Indexed keywords

ANTIBODY; ESTROGEN RECEPTOR; PARAFFIN; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; LABORATORY; PROTEIN ANALYSIS; REPRODUCIBILITY; TISSUE SECTION;

EID: 0036933129     PISSN: 01478885     EISSN: None     Source Type: Journal    
DOI: 10.1179/his.2002.25.4.283     Document Type: Article

References (13)

1. NIH Consensus Statement - Adjuvant Therapy for Breast Cancer. National Institutes of Health, Washington, DC, 17:1-35, 2000
2. Battifora H: Immunocytochemistry of hormone receptors in routinely processed tissues. The new gold standard. Appl Immunohistochem 2:143-145, 1994
3. Pertschuk LP, Feldman JG, Kim Y-D, Braithwaite L, Schneider F, Braverman AS, Axiotis C: Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol-based ligand-binding assays. Cancer 77:2514-2519, 1996
4. Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155-168, 1998
5. Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474-1481, 1999
6. Shintaku IP, Said JW: Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Am J Clin Pathol 87:161-167, 1987
7. Goulding H, Pinder S, Cannon P, Pearson D, Nicholson R, Snead D, Bell J, Elston CWE, Robertson JF, Blamey RW, Ellis IO: A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol 26:291-294, 1995.
8. MacGrogan G, Soubeyran I, De Mascarel I, Wafflart J, Bonichon F, Durand M, Avril A, Mauriac, Trojani M, Coindre JM: Immunohistochemical detection of progesterone receptors in breast invasive ductal carcinomas. Appl Immunohistochem 4:219-227, 1996
9. Bevitt DJ, Milton ID, Piggot N, Henry L, Carter MJ, Toms GL, Lennard TWJ, Westley B, Angus B, Horne CHW: New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry. J Pathol 183:228-232, 1997
10. Leake R, Barnes D, Pinder S, Ellis I, Anderson L, Anderson T, Adamson R, Rhodes T, Miller K, Walker R: Immunohistochemical detection of steroid receptors in breast cancer: A working protocol. J Clin Pathol 53:634-635, 2000
11. Vyberg M, Nielsen S: Dextran polymer conjugate two-step visualization system for immunohistochemistry. Appl Immunohistochem 6:3-10, 1998
12. Dabbs DJ: Diagnostic immunohistochemistry of the breast. In Diagnostic Immunohistochemistry, Churchill Livingstone, Philadelphia, PA, 2002, pp 536-558
13. Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisenberg KB, Carter AC, Rong ZT, Thelmo WL, Fleisher J, Greene GL: Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies: Histopathologic, demographic and biochemical correlations and relationships to endocrine response and survival. Cancer 66:1663-1670, 1990